HK1205463A1 - 含有 -羥基- -咪唑- -甲酰胺的片劑 - Google Patents

含有 -羥基- -咪唑- -甲酰胺的片劑

Info

Publication number
HK1205463A1
HK1205463A1 HK15106090.9A HK15106090A HK1205463A1 HK 1205463 A1 HK1205463 A1 HK 1205463A1 HK 15106090 A HK15106090 A HK 15106090A HK 1205463 A1 HK1205463 A1 HK 1205463A1
Authority
HK
Hong Kong
Prior art keywords
carboxamide
imidazole
hydroxy
tablet containing
tablet
Prior art date
Application number
HK15106090.9A
Other languages
English (en)
Inventor
山崎泰臣
Original Assignee
富士膠片株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 富士膠片株式會社 filed Critical 富士膠片株式會社
Publication of HK1205463A1 publication Critical patent/HK1205463A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15106090.9A 2013-01-15 2015-06-26 含有 -羥基- -咪唑- -甲酰胺的片劑 HK1205463A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013004995 2013-01-15
PCT/JP2014/050591 WO2014112530A1 (ja) 2013-01-15 2014-01-15 ５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミドを含有する錠剤

Publications (1)

Publication Number Publication Date
HK1205463A1 true HK1205463A1 (zh) 2015-12-18

Family

ID=51209619

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106090.9A HK1205463A1 (zh) 2013-01-15 2015-06-26 含有 -羥基- -咪唑- -甲酰胺的片劑

Country Status (17)

Country Link
US (1) US9248102B2 (zh)
EP (1) EP2946780B1 (zh)
JP (1) JP5805891B2 (zh)
CN (1) CN104271134B (zh)
BR (1) BR112014027231A2 (zh)
CY (1) CY1119159T1 (zh)
DK (1) DK2946780T3 (zh)
ES (1) ES2622568T3 (zh)
HK (1) HK1205463A1 (zh)
HR (1) HRP20170571T1 (zh)
LT (1) LT2946780T (zh)
PL (1) PL2946780T3 (zh)
PT (1) PT2946780T (zh)
RS (1) RS56032B1 (zh)
RU (1) RU2654703C2 (zh)
SI (1) SI2946780T1 (zh)
WO (1) WO2014112530A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
JP6823660B2 (ja) * 2016-09-13 2021-02-03 富士フイルム株式会社 Ｍｌｌ関連白血病の予防または治療のための医薬、方法、使用及び化合物
WO2019082898A1 (ja) 2017-10-27 2019-05-02 富士フイルム株式会社 ５－ヒドロキシ－１ｈ－イミダゾール－４－カルボキサミド・３／４水和物の製造方法
RU2018134165A (ru) * 2018-09-03 2020-04-01 Фуджифилм Корпорэйшн Комбинированное фармацевтическое, профилактическое или супрессивное средство для подавления резистентности к пиримидиновому антиметаболиту и способ лечения заболевания

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604802B2 (ja) 1976-09-07 1985-02-06 住友化学工業株式会社 制癌剤
US4181731A (en) * 1976-09-07 1980-01-01 Sumitomo Chemical Company, Limited Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole
JPS5824569A (ja) 1981-08-05 1983-02-14 Sumitomo Chem Co Ltd イミダゾ−ル誘導体の精製方法
JPS60185727A (ja) 1984-03-05 1985-09-21 Sumitomo Chem Co Ltd ４−カルバモイルイミダゾリウム−５−オレ−ト製剤の安定化法
JPH048468A (ja) * 1990-04-27 1992-01-13 Sanshin:Kk ワーク研摩機
JPH09208468A (ja) * 1996-02-02 1997-08-12 Dainippon Pharmaceut Co Ltd ｐ−クロロ−Ｎ−（２−モルホリノエチル）ベンズアミドを含有する錠剤
KR20070072888A (ko) * 2004-10-25 2007-07-06 니뽄 다바코 산교 가부시키가이샤 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법
JP5021210B2 (ja) * 2006-01-16 2012-09-05 エスエス製薬株式会社 圧縮成型製剤
FR2903695B1 (fr) * 2006-07-13 2008-10-24 Merck Sante Soc Par Actions Si Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP5266010B2 (ja) 2007-09-14 2013-08-21 富士フイルム株式会社 ４−カルバモイル−５−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物
EP2407166B1 (en) * 2009-03-13 2013-08-21 Toyama Chemical Co., Ltd. Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide

Also Published As

Publication number Publication date
EP2946780A4 (en) 2016-06-08
EP2946780A1 (en) 2015-11-25
RU2654703C2 (ru) 2018-05-22
US20150057324A1 (en) 2015-02-26
JP5805891B2 (ja) 2015-11-10
SI2946780T1 (sl) 2017-05-31
WO2014112530A1 (ja) 2014-07-24
CN104271134B (zh) 2016-06-29
LT2946780T (lt) 2017-06-12
HRP20170571T1 (hr) 2017-08-11
JPWO2014112530A1 (ja) 2017-01-19
PT2946780T (pt) 2017-04-26
CY1119159T1 (el) 2018-02-14
RU2014143976A (ru) 2016-05-27
DK2946780T3 (en) 2017-05-08
BR112014027231A2 (pt) 2017-06-27
EP2946780B1 (en) 2017-03-01
RS56032B1 (sr) 2017-09-29
US9248102B2 (en) 2016-02-02
PL2946780T3 (pl) 2017-07-31
ES2622568T3 (es) 2017-07-06
CN104271134A (zh) 2015-01-07

Similar Documents

Publication Publication Date Title
ZA201508571B (en) Modular tablet case
GB201306312D0 (en) Tablet case
GB201413149D0 (en) No details
AU354395S (en) Case
GB201302901D0 (en) Ubuntu tablet
GB201506699D0 (en) No details
GB201410903D0 (en) No details
GB201518344D0 (en) No details present
GB201421649D0 (en) No details
GB201418212D0 (en) No details
GB201300112D0 (en) Pill Container
GB201418129D0 (en) No details
GB201421548D0 (en) No details
GB201408089D0 (en) No details
GB201418214D0 (en) No details
GB201416327D0 (en) No details
DK3627858T3 (en) Telefonophæng til et høreapparat
IL241350A0 (en) Subprevir tablets
PT3046548T (pt) Comprimido compreendendo crospovidona
GB201407200D0 (en) No details
HK1205463A1 (zh) 含有 -羥基- -咪唑- -甲酰胺的片劑
GB201417843D0 (en) No details
SG11201504474VA (en) Case unit
EP3069714A4 (en) Tablet
GB201420520D0 (en) No details

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210114